BACKGROUND: This study was conducted to determine whether increased body mass
index (BMI) affects oral contraceptive (OC) pharmacokinetics and suppression of …

Objective To determine if increasing the hormone dose or eliminating the hormone-free
interval improves key pharmacokinetic (PK) alterations caused by obesity during oral …

BACKGROUND: This study was conducted to compare oral contraceptive (OC)
pharmacokinetics (PK) in normal-weight [body mass index (BMI) 19.0–24.9] and obese (BMI …

The rising rate of overweight and obesity is a public health crisis in the United States and
increasingly around the globe. Rates of contraceptive use are similar among women of all …

BACKGROUND: Pharmacokinetic (PK) parameters based on short sampling times (48 h or
less) may contain inaccuracies due to their dependency on extrapolated values. This study …

OBJECTIVE: To assess ovarian suppression during oral contraceptive pill (OCP) use among
normal-weight and obese women using two OCP doses. METHODS: This was a …

Oral contraceptive pills (OCPs) are the most popular form of reversible contraception in the
United States [1]. Most commonly used OCPs contain a combination of estrogen and …

Objective The objective of this investigation was to assess the potential effect of obesity on
the effectiveness of hormonal contraceptives (HCs). Study Design A meta-analysis was …

Obesity is a major public health concern affecting an increasing proportion of reproductive-
aged women. Avoiding unintended pregnancy is of major importance, given the increased …

BACKGROUND: This analysis investigated the association of oral contraceptive efficacy with
body weight and body mass index (BMI) for hypothesis-generating purposes. STUDY …